These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18541578)

  • 1. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality.
    Watanabe M; Suliman ME; Qureshi AR; Garcia-Lopez E; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
    Am J Clin Nutr; 2008 Jun; 87(6):1860-6. PubMed ID: 18541578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.
    Yuan J; Watanabe M; Suliman M; Qureshi AR; Axelsson J; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Feb; 30(2):274-82. PubMed ID: 23975839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
    Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
    J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on inflammation in chronic kidney disease.
    Akchurin OM; Kaskel F
    Blood Purif; 2015; 39(1-3):84-92. PubMed ID: 25662331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.
    Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimbürger O; Barany P; Lindholm B; Stenvinkel P
    Eur J Intern Med; 2019 Oct; 68():60-65. PubMed ID: 31402276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and Progression of CKD: The CRIC Study.
    Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.
    Stenvinkel P; Wang K; Qureshi AR; Axelsson J; Pecoits-Filho R; Gao P; Barany P; Lindholm B; Jogestrand T; Heimbürger O; Holmes C; Schalling M; Nordfors L
    Kidney Int; 2005 Jun; 67(6):2383-92. PubMed ID: 15882283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
    Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease.
    Suliman ME; Qureshi AR; Stenvinkel P; Pecoits-Filho R; Bárány P; Heimbürger O; Anderstam B; Rodríguez Ayala E; Divino Filho JC; Alvestrand A; Lindholm B
    Am J Clin Nutr; 2005 Aug; 82(2):342-9. PubMed ID: 16087977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.
    Stenvinkel P; Heimbürger O; Paultre F; Diczfalusy U; Wang T; Berglund L; Jogestrand T
    Kidney Int; 1999 May; 55(5):1899-911. PubMed ID: 10231453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.
    Qureshi AR; Alvestrand A; Danielsson A; Divino-Filho JC; Gutierrez A; Lindholm B; Bergström J
    Kidney Int; 1998 Mar; 53(3):773-82. PubMed ID: 9507226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.